Communicable disease threats report, 19-25 September, week 39
September 26, 2026
The EU experience in the first phase of COVID-19: implications for measuring preparedness
This technical report presents an analysis focusing on three issues (testing and surveillance, healthcare sector coordination, and emergency risk communication) during the first phase of the COVID-19 pandemic.
Communicable disease threats report, 18-24 September 2022, week 38
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 September 2022 and includes updates on cholera, polio, COVID-19, monkeypox, West Nile virus, and Ebola virus disease.
Pilot protocol for a COVID-19 vaccine effectiveness study using health data registries
This pilot protocol is primarily intended to guide the implementation of a first pilot ECDC-funded study using routinely collected data, and includes a concise overview of the systems of the countries included in the pilot study.
Communicable disease threats report, 11-17 September 2022, week 37
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11-17 September 2022 and includes updates on COVID-19, monkeypox, West Nile virus infection, dengue, and poliovirus.
Evidence-based decision making: After-action review on long-term care facilities in Georgia
On 7 – 9 September 2022, ECDC organised with the Ministry of Health and the Georgian National Center for Disease Control and Public Health a consultative meeting with Georgian public health representatives and stakeholders.
Communicable disease threats report, 4-10 September 2022, week 36
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 September 2022 and includes updates on COVID-19, monkeypox, West Nile virus infection, Ebola, Vibrio growth, dengue, and MERS-CoV.
COVID-19: recommendations on use of adapted vaccines
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement (link) providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns.
Communicable disease threats report, 28 August-3 September 2022, week 35
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 August-3 September 2022 and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis cases of unknown aetiology in children, Vibrio, and poliomyelitis.
Long-term qualitative scenarios and considerations of their implications for preparedness and response to the COVID-19 pandemic in the EU/EEA
This document sets out a number of scenarios that are intended to be plausible, internally consistent, and coherent descriptions of possible futures.
COVID-19 and other respiratory viruses: mitigating their spread as children return to school across Europe
In order to maintain safe school environments and minimise student and staff absences, it is important to continue ensuring the prevention of the transmission of respiratory viruses such as influenza, respiratory syncytial virus (RSV), norovirus and SARS-CoV-2.
